XML 37 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Current assets      
Cash and cash equivalents $ 13,597 $ 264,538 $ 392,446
Prepaid expenses 20,250 377,780
Cash and marketable securities held in Trust Account 1,423,594 29,728,990
Total Current Assets 1,560,441 29,993,528 770,226
Cash held in Trust Account 6,297,612 7,372,451 309,790,455
TOTAL ASSETS 7,858,053 37,365,979 310,560,681
Current liabilities      
Accounts payable and accrued expenses 1,739,989 469,268 1,243,172
Excise tax payable 3,076,240 3,062,004
Accrued offering costs 5,000 5,000 75,000
Income taxes payable 366,161 308,194 823,991
Total Current Liabilities 9,041,035 35,388,456 2,142,163
Deferred underwriting fee payable 10,500,000 10,500,000 10,500,000
Total Liabilities 19,541,035 45,888,456  
Commitments (Note 6)
Common stock subject to possible redemption 6,127,635 7,292,641 309,097,930
Stockholders’ Deficit      
Preferred stock value
Additional paid-in capital
Accumulated deficit (17,811,367) (15,815,868) (11,180,162)
Total Stockholders’ Deficit (17,810,617) (15,815,118) (11,179,412)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 7,858,053 37,365,979 310,560,681
Related Party      
Current assets      
Due from related party- Abpro 103,000  
Current liabilities      
Extension promissory note - related party 160,000 160,000
Advance from related parties 2,270,051 1,655,000
Previously Reported      
Current liabilities      
Total Liabilities   45,888,457 12,642,163
Series A Common Stock      
Current liabilities      
Common stock to be redeemed 1,423,594 29,728,990
Stockholders’ Deficit      
Common stock value 749 749
Series B Common Stock      
Stockholders’ Deficit      
Common stock value $ 1 $ 1 $ 750